Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6391]

Final results of phase 1 clinical trial of preventive breast cancer vaccine study

Final results of phase 1 clinical trial of preventive breast cancer vaccine study

Researchers find new way to deliver antibodies that could make treatment much easier for patients

Researchers find new way to deliver antibodies that could make treatment much easier for patients

Study explores why some drug therapies are ineffective for brain tumour patients

Study explores why some drug therapies are ineffective for brain tumour patients

New horizons in NSCLC targeted therapy: advancements and challenges

New horizons in NSCLC targeted therapy: advancements and challenges

Study identifies immune switch critical to autoimmunity and cancer

Study identifies immune switch critical to autoimmunity and cancer

$SABCS 2025: Sacituzumab govitecan-hziy led to similar progression-free survival as standard of care for certain endocrine therapy-refractory advanced breast cancers$

SABCS 2025: Sacituzumab govitecan-hziy led to similar progression-free survival as standard of care for certain...

ASH 2025: Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

ASH 2025: Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers 

$ASH 2025: Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma$

ASH 2025: Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or...

ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL

ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL

More from ecancer